Abbott Laboratories Stock Today

ABT Stock  USD 113.48  1.98  1.78%   

Performance

2 of 100

 
Low
 
High
Weak

Odds Of Distress

Less than 5

 
100  
 
Zero
Very Low
Abbott Laboratories is selling for under 113.48 as of the 28th of March 2024; that is 1.78 percent increase since the beginning of the trading day. The stock's last reported lowest price was 112.0. Abbott Laboratories has under 5 % chance of experiencing financial distress over the next 2 years but had a somewhat weak performance during the last 90 days. Equity ratings for Abbott Laboratories are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of March 2023 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
13th of January 1978
Category
Healthcare
Classification
Health Care
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 1.74 B outstanding shares of which 14.92 M shares are presently shorted by investors with about 2.72 days to cover. More on Abbott Laboratories

Moving against Abbott Stock

  0.56SSY SunLink Health SystemsPairCorr
  0.47FIGS Figs Inc Financial Report 2nd of May 2024 PairCorr
  0.47TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.44CVS CVS Health Corp Financial Report 1st of May 2024 PairCorr
  0.43CMAXW CareMaxPairCorr
  0.43DYNT Dynatronics Financial Report 9th of May 2024 PairCorr

Abbott Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Abbott Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abbott Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.
Environment Score
Governance Score
Social Score
CEORobert Ford
Thematic Ideas
(View all Themes)
Old Names[Absolute Software Corporation, Abbott Laboratories, Aqua Bio Technology ASA, Abundant Produce Limited, Abbott Laboratories]
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, SP 100 Index, SP 100, NYSE US 100, ARCA Institutional, Obamacare Repeal, SRI Sustainable Growth, Compulsion, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal TestingCatholic
Average Analyst Recommendation
Analysts covering Abbott Laboratories report their recommendations after researching Abbott Laboratories' financial statements, talking to executives and customers, or listening in on Abbott Laboratories' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Abbott Laboratories. The Abbott consensus assessment is calculated by taking the average forecast from all of the analysts covering Abbott Laboratories.
Financial Strength
Based on the key indicators related to Abbott Laboratories' liquidity, profitability, solvency, and operating efficiency, Abbott Laboratories may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Abbott Laboratories is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.120.0782
Way Up
Very volatile
Asset Turnover0.840.5478
Way Up
Pretty Stable
Gross Profit Margin0.620.4996
Fairly Up
Very volatile
Net Debt6.1 BB
Way Down
Slightly volatile
Total Current Liabilities8.3 B13.8 B
Way Down
Slightly volatile
Non Current Liabilities Total11.7 B20.5 B
Way Down
Slightly volatile
Total Assets36.9 B73.2 B
Way Down
Slightly volatile
Total Current Assets13.3 B22.7 B
Way Down
Pretty Stable
Total Cash From Operating Activities5.2 B7.3 B
Way Down
Slightly volatile
Abbott Laboratories' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Abbott Laboratories' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Abbott Laboratories' bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Abbott Laboratories' outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Abbott Laboratories' financial leverage. It provides some insight into what part of Abbott Laboratories' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Abbott Laboratories' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Abbott Laboratories deploys its capital and how much of that capital is borrowed.
Liquidity
Abbott Laboratories cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 15.87 B in debt with debt to equity (D/E) ratio of 0.46, which is OK given its current industry classification. Abbott Laboratories has a current ratio of 1.82, which is typical for the industry and considered as normal. Debt can assist Abbott Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Abbott Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Abbott Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Abbott to invest in growth at high rates of return. When we think about Abbott Laboratories' use of debt, we should always consider it together with cash and equity.

Other Non Cash Items

9.06 Billion
Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA. It is located in 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400 and employs 114,000 people. Abbott Laboratories is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 193.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Abbott Laboratories runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 1.74 B outstanding shares of which 14.92 M shares are presently shorted by investors with about 2.72 days to cover. Abbott Laboratories has about 9.88 B in cash with 7.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.68.
Check Abbott Laboratories Probability Of Bankruptcy
Ownership Allocation
Abbott Laboratories retains a total of 1.74 Billion outstanding shares. The majority of Abbott Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbott Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbott Laboratories. Please pay attention to any change in the institutional holdings of Abbott Laboratories as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Abbott Ownership Details

Abbott Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Abbott Laboratories jumping above the current price in 90 days from now is about 56.51%. The Abbott Laboratories probability density function shows the probability of Abbott Laboratories stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Abbott Laboratories has a beta of 0.81. This suggests as returns on the market go up, Abbott Laboratories average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Abbott Laboratories will be expected to be much smaller as well. Additionally, abbott Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 113.48HorizonTargetOdds Above 113.48
43.14%90 days
 113.48 
56.51%
Based on a normal probability distribution, the odds of Abbott Laboratories to move above the current price in 90 days from now is about 56.51 (This Abbott Laboratories probability density function shows the probability of Abbott Stock to fall within a particular range of prices over 90 days) .

Abbott Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Abbott Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Abbott Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Abbott Laboratories' value.
InstituionRecorded OnShares
Wells Fargo & Co2023-12-31
16.5 M
Bank Of America Corp2023-12-31
16.4 M
Bank Of New York Mellon Corp2023-12-31
15.1 M
Legal & General Group Plc2023-12-31
14.3 M
State Farm Mutual Automobile Ins Co2023-12-31
13.6 M
Polen Capital2023-12-31
13.5 M
Jpmorgan Chase & Co2023-12-31
13.3 M
Hhg Plc2023-12-31
13.2 M
Nuveen Asset Management, Llc2023-12-31
12.4 M
Vanguard Group Inc2023-12-31
156.4 M
Blackrock Inc2023-12-31
134.1 M
View Abbott Laboratories Diagnostics

Abbott Laboratories Historical Income Statement

Abbott Laboratories Income Statement is one of the three primary financial statements used for reporting Abbott's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Abbott Laboratories revenue and expense. Abbott Laboratories Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Abbott Laboratories' Depreciation And Amortization is comparatively stable compared to the past year. Cost Of Revenue is likely to gain to about 21.1 B in 2024, whereas Total Revenue is likely to drop slightly above 22.2 B in 2024. View More Fundamentals

Abbott Stock Against Markets

Picking the right benchmark for Abbott Laboratories stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Abbott Laboratories stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Abbott Laboratories is critical whether you are bullish or bearish towards Abbott Laboratories at a given time. Please also check how Abbott Laboratories' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Abbott Laboratories Corporate Directors

Abbott Laboratories corporate directors refer to members of an Abbott Laboratories board of directors. The board of directors generally takes responsibility for the Abbott Laboratories' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Abbott Laboratories' board members must vote for the resolution. The Abbott Laboratories board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Samuel ScottIndependent DirectorProfile
James FarrellIndependent DirectorProfile
Phebe NovakovicIndependent DirectorProfile
Roxanne AustinIndependent DirectorProfile

How to buy Abbott Stock?

Before investing in Abbott Laboratories, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Abbott Laboratories. To buy Abbott Laboratories stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Abbott Laboratories. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Abbott Laboratories stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Abbott Laboratories stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Abbott Laboratories stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Abbott Laboratories, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Already Invested in Abbott Laboratories?

The danger of trading Abbott Laboratories is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abbott Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abbott Laboratories. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abbott Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.
Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stocks Directory
Find actively traded stocks across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.55
Dividend Share
2.08
Earnings Share
3.26
Revenue Per Share
23.051
Quarterly Revenue Growth
0.015
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.